28 March, 2017 by The TZ Newswire Staff Comments Off on Divisa Capital Hires Hormoz Faryar from ADS Securities
Divisa Capital Hires Hormoz Faryar from ADS Securities
Divisa’s new hire will serve as Global Head of Institutional Sales
28 March, 2017 by The TZ Newswire Staff Comments Off on Divisa Capital Hires Hormoz Faryar from ADS Securities
Divisa Capital Hires Hormoz Faryar from ADS Securities
Divisa’s new hire will serve as Global Head of Institutional Sales
28 March, 2017 by The TZ Newswire Staff Comments Off on Need to Know: This big test is coming for our ‘Teflon’ stock market
Need to Know: This big test is coming for our ‘Teflon’ stock market
It seems not much is going to get this stock market down.
28 March, 2017 by The TZ Newswire Staff Comments Off on Need to Know: This big test is coming for our ‘Teflon’ stock market
Need to Know: This big test is coming for our ‘Teflon’ stock market
It seems not much is going to get this stock market down.
28 March, 2017 by The TZ Newswire Staff Comments Off on Currencies: Dollar rebounds in step with stocks’ attempt to halt skid
Currencies: Dollar rebounds in step with stocks’ attempt to halt skid
The dollar rebounded mildly Tuesday in step with what’s shaping up to be the first gain for the Dow industrials in nine sessions, although the stock advance remained vulnerable.
read more
28 March, 2017 by The TZ Newswire Staff Comments Off on Currencies: Dollar rebounds in step with stocks’ attempt to halt skid
Currencies: Dollar rebounds in step with stocks’ attempt to halt skid
The dollar rebounded mildly Tuesday in step with what’s shaping up to be the first gain for the Dow industrials in nine sessions, although the stock advance remained vulnerable.
read more
28 March, 2017 by The TZ Newswire Staff Comments Off on 3 Least Risky Biotech Stocks on the Market
3 Least Risky Biotech Stocks on the Market
Biotech stocks are notoriously risky investments. But not every biotech carries as much risk as others.
Three biotech stocks could be the least risky of all: Celgene (NASDAQ: CELG), Ligand Pharmaceuticals (NASDAQ: LGND), and Gilead Sciences (NASDAQ: GILD). Here’s why these stocks shouldn’t be quite as volatile in the months and years ahead.
Image source: Getty Images.